Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.9K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.9K
Chronic Pharyngitis01:23

Chronic Pharyngitis

10.6K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
10.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ocrelizumab B cell depletion has no effect on HERV RNA expression in PBMC in MS patients.

Multiple sclerosis and related disorders·2024
Same author

Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis.

Frontiers in immunology·2023
Same author

The Potential for EBV Vaccines to Prevent Multiple Sclerosis.

Frontiers in neurology·2022
Same author

Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids.

PLoS pathogens·2021
Same author

Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells.

Blood·2021
Same author

BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphoma.

Blood advances·2020
Same journal

Resolution Failure in Periodontal Diseases: Dysregulated Pro-resolving Mechanisms in Chronic Inflammation and Tissue Breakdown.

Current topics in microbiology and immunology·2026
Same journal

Correction to: Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

Current topics in microbiology and immunology·2026
Same journal

Resolution Biology in Soft Tissue Joint Disease.

Current topics in microbiology and immunology·2026
Same journal

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same journal

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same journal

Resolution Pharmacology Targeting the Melanocortin System.

Current topics in microbiology and immunology·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.6K

Systemic Chronic Active Epstein-Barr Virus Disease.

Claire Shannon-Lowe1

  • 1Department of Immunology and Immunotherapy, College of Medicine and Health, The University of Birmingham, Birmingham, UK. c.shannonlowe@bham.ac.uk.

Current Topics in Microbiology and Immunology
|December 2, 2025
PubMed
Summary
This summary is machine-generated.

Systemic chronic active Epstein-Barr virus (CAEBV) disease affects individuals without immune defects, leading to severe inflammation and organ failure. Understanding CAEBV pathogenesis is key for developing targeted therapies.

More Related Videos

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.8K
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.5K

Related Experiment Videos

Last Updated: Jan 9, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.6K
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.8K
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.5K

Area of Science:

  • Virology
  • Immunology
  • Pathogenesis

Background:

  • Epstein-Barr virus (EBV) establishes lifelong B cell persistence.
  • EBV-associated diseases typically occur in immunocompromised individuals.
  • Systemic chronic active EBV (CAEBV) disease presents without apparent immune defects.

Purpose of the Study:

  • To summarize current understanding of systemic CAEBV pathogenesis.
  • To identify factors contributing to CAEBV development and progression.
  • To highlight potential targets for precision medicine.

Main Methods:

  • Review of current literature on CAEBV.
  • Analysis of viral, genetic, and immunologic factors in CAEBV.
  • Synthesis of data on disease progression and treatment targets.

Main Results:

  • CAEBV involves uncontrolled EBV infection in T cells/NK cells.
  • Characterized by systemic inflammation and high EBV DNA loads.
  • Leads to life-threatening conditions like HLH, organ failure, and lymphomas.

Conclusions:

  • CAEBV pathogenesis is complex, involving viral, genetic, and immune factors.
  • Further research can identify targets for precision medicine.
  • Understanding these factors is crucial for managing severe EBV infections.